|

PD1+ TILs (NUMARZU-001) product infusion Clinical Trials

1 actively recruiting trial

Also known as: TILs

Pipeline

Phase 1/2: 1

Top Sponsors

  • Fundacio Clinic Barcelona1

Indications

  • Metastatic Triple-Negative Breast Carcinoma1
  • Breast Cancer1
  • Cancer1

Other1 trial

Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.